Dr. Golshayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2610 Aberdeen Blvd
Gastonia, NC 28054Phone+1 980-442-4500Fax+1 828-324-4154
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2004 - 2007
- Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
- University of Vermont College of MedicineClass of 2001
Certifications & Licensure
- NC State Medical License 2014 - 2025
- SC State Medical License 2008 - 2015
- OH State Medical License 2001 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 1580 citationsPrognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From ...Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Mark Andrew Warren, Ali Reza Golshayan
Journal of Clinical Oncology. 2009-12-01 - 668 citationsSunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma PatientsJennifer S. Ko, Arnold H. Zea, Brian I. Rini, Joanna Ireland, Paul Elson
Clinical Cancer Research. 2009-03-15 - 384 citationsSunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma PatientsJames H. Finke, Brian I. Rini, Joanna Ireland, Patricia Rayman, Amy Richmond
Clinical Cancer Research. 2008-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: